Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers

被引:79
作者
Civiero, Laura [1 ]
Vancraenenbroeck, Renee [2 ,3 ]
Belluzzi, Elisa [1 ]
Beilina, Alexandra [4 ]
Lobbestael, Evy [2 ]
Reyniers, Lauran [2 ]
Gao, Fangye [2 ]
Micetic, Ivan [1 ]
De Maeyer, Marc [3 ]
Bubacco, Luigi [1 ]
Baekelandt, Veerle [2 ]
Cookson, Mark R. [4 ]
Greggio, Elisa [1 ]
Taymans, Jean-Marc [2 ]
机构
[1] Univ Padua, Dept Biol, Padua, Italy
[2] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium
[3] Katholieke Univ Leuven, Lab Biomol Modelling, B-3001 Heverlee, Belgium
[4] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, Bethesda, MD 20892 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
基金
比利时弗兰德研究基金会; 美国国家卫生研究院;
关键词
DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; GTP-BINDING; ROC DOMAIN; DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LRRK2; GENE; LEUCINE-RICH-REPEAT-KINASE-2; PROTEINS;
D O I
10.1371/journal.pone.0043472
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Leucine-rich repeat kinase 1 and 2 (LRRK1 and LRRK2) are large multidomain proteins containing kinase, GTPase and multiple protein-protein interaction domains, but only mutations in LRRK2 are linked to familial Parkinson's disease (PD). Independent studies suggest that LRRK2 exists in the cell as a complex compatible with the size of a dimer. However, whether this complex is truly a homodimer or a heterologous complex formed by monomeric LRRK2 with other proteins has not been definitively proven due to the limitations in obtaining highly pure proteins suitable for structural characterization. Here, we used stable expression of LRRK1 and LRRK2 in HEK293T cell lines to produce recombinant LRRK1 and LRRK2 proteins of greater than 90% purity. Both purified LRRKs are folded, with a predominantly alpha-helical secondary structure and are capable of binding GTP with similar affinity. Furthermore, recombinant LRRK2 exhibits robust autophosphorylation activity, phosphorylation of model peptides in vitro and ATP binding. In contrast, LRRK1 does not display significant autophosphorylation activity and fails to phosphorylate LRRK2 model substrates, although it does bind ATP. Using these biochemically validated proteins, we show that LRRK1 and LRRK2 are capable of forming homodimers as shown by single-particle transmission electron microscopy and immunogold labeling. These LRRK dimers display an elongated conformation with a mean particle size of 145 angstrom and 175 angstrom respectively, which is disrupted by addition of 6M guanidinium chloride. Immunogold staining revealed double-labeled particles also in the pathological LRRK2 mutant G2019S and artificial mutants disrupting GTPase and kinase activities, suggesting that point mutations do not hinder the dimeric conformation. Overall, our findings indicate for the first time that purified and active LRRK1 and LRRK2 can form dimers in their full-length conformation.
引用
收藏
页数:14
相关论文
共 63 条
[1]   Investigation of leucine-rich repeat kinase 2 [J].
Anand, Vasanti S. ;
Reichling, Laurie J. ;
Lipinski, Kerri ;
Stochaj, Wayne ;
Duan, Weili ;
Kelleher, Kerry ;
Pungaliya, Pooja ;
Brown, Eugene L. ;
Reinhart, Peter H. ;
Somberg, Richard ;
Hirst, Warren D. ;
Riddle, Steven M. ;
Braithwaite, Steven P. .
FEBS JOURNAL, 2009, 276 (02) :466-478
[2]   Characterization of lentiviral vector-mediated gene transfer in adult mouse brain [J].
Baekelandt, V ;
Claeys, A ;
Eggermont, K ;
Lauwers, E ;
De Strooper, B ;
Nuttin, B ;
Debyser, Z .
HUMAN GENE THERAPY, 2002, 13 (07) :841-853
[3]   Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation [J].
Berger, Zdenek ;
Smith, Kelsey A. ;
LaVoie, Matthew J. .
BIOCHEMISTRY, 2010, 49 (26) :5511-5523
[4]   Roc, a Ras/GTPase domain in complex proteins [J].
Bosgraaf, L ;
Van Haastert, PJM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3) :5-10
[5]   Charting the molecular network of the drug target Bcr-Abl [J].
Brehme, Marc ;
Hantschel, Oliver ;
Colinge, Jacques ;
Kaupe, Ines ;
Planyavsky, Melanie ;
Koecher, Thomas ;
Mechtler, Karl ;
Bennett, Keiryn L. ;
Superti-Furga, Giulio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) :7414-7419
[6]   GTP binding to the ROC domain of DAP-kinase regulates its function through intramolecular signalling [J].
Carlessi, Rodrigo ;
Levin-Salomon, Vered ;
Ciprut, Sara ;
Bialik, Shani ;
Berissi, Hanna ;
Albeck, Shira ;
Peleg, Yoav ;
Kimchi, Adi .
EMBO REPORTS, 2011, 12 (09) :917-923
[7]   The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition [J].
Covy, Jason P. ;
Giasson, Benoit I. .
JOURNAL OF NEUROCHEMISTRY, 2010, 115 (01) :36-46
[8]   Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant [J].
Daniels, Veronique ;
Vancraenenbroeck, Renee ;
Law, Bernard M. H. ;
Greggio, Elisa ;
Lobbestael, Evy ;
Gao, Fangye ;
De Maeyer, Marc ;
Cookson, Mark R. ;
Harvey, Kirsten ;
Baekelandt, Veerle ;
Taymans, Jean-Marc .
JOURNAL OF NEUROCHEMISTRY, 2011, 116 (02) :304-315
[9]   Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase [J].
Deng, Junpeng ;
Lewis, Patrick A. ;
Greggio, Elisa ;
Sluch, Eli ;
Beilina, Alexandra ;
Cookson, Mark R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1499-1504
[10]   Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 [J].
Deng, Xianming ;
Dzamko, Nicolas ;
Prescott, Alan ;
Davies, Paul ;
Liu, Qingsong ;
Yang, Qingkai ;
Lee, Jiing-Dwan ;
Patricelli, Matthew P. ;
Nomanbhoy, Tyzoon K. ;
Alessi, Dario R. ;
Gray, Nathanael S. .
NATURE CHEMICAL BIOLOGY, 2011, 7 (04) :203-205